Koren, M. ., Giugliano, R. ., Raal, F. ., Sullivan, D. ., Bolognese, M. ., Langslet, G. ., … OSLER, I. . (2014). Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. Circulation, 129(2), 234-43. https://doi.org/10.1161/CIRCULATIONAHA.113.007012 (Original work published 2014)

Gray, H. ., Bell-McGuinn, K. ., Fleming, G. ., Cristea, M. ., Xiong, H. ., Sullivan, D. ., … Martin, L. . (2018). Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.12.029 (Original work published 2018)

Mao, C. ., Howard, T. ., Sullivan, D. ., Fu, Z. ., Yu, G. ., Parker, S. ., … Herrington, D. . Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis. Journal of Proteomics and Genomics Research, 2(1), 1-12. https://doi.org/10.14302/issn.2326-0793.jpgr-17-1447 (Original work published 2017)

Reilly, E. ., Bohrer, B. ., Sullivan, D. ., Essayli, J. ., Farrell, N. ., Brown, T. ., … Schaumberg, K. . (2021). Registered report: Initial development and validation of the eating disorders safety behavior scale. The International Journal of Eating Disorders, 54(4), 660-667. https://doi.org/10.1002/eat.23479